Reshoring pharmaceutical production is expensive, so companies will still find it cheaper to manufacture overseas, shifting reliance from China to India and Southeast Asia.
As heard by us
Tariff pressure reshaped pharma manufacturing before policy fully landed.
Fraser Kansteiner and Brady McKinney frame tariff pressure as a manufacturing story, and the piece stays steady on that line. It traces how repeated tariff threats pushed drug makers around the world to ramp production in 2025, build inventory, and brace for trade disruption.
Why you'd press play
Tariffs changed the factory math before the rules settled.
Listen to the show on